Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I
(Q45752944)
scientific article published in October 1998
scientific article published in October 1998
Language:
other details
description | scientific article published in October 1998 |
External Links
(P356) |
10.1016/S0140-6736(98)07124-4
|
(P698) |
9807989
|